The methamphetamine epidemic among persons who inject heroin in Hai Phong, Vietnam.


Journal

Journal of substance abuse treatment
ISSN: 1873-6483
Titre abrégé: J Subst Abuse Treat
Pays: United States
ID NLM: 8500909

Informations de publication

Date de publication:
07 2021
Historique:
received: 15 04 2020
revised: 11 11 2020
accepted: 31 01 2021
entrez: 12 6 2021
pubmed: 13 6 2021
medline: 6 8 2021
Statut: ppublish

Résumé

To describe the current methamphetamine (MA) use epidemic among persons who inject heroin (PWID) in Hai Phong, Vietnam, and consider possibilities for mitigating adverse effects of methamphetamine use. This study conducted surveys of PWID in 2016, 2017, and 2018 (N = 1383, 1451, and 1445, respectively). Trained interviewers administered structured interviews covering drug use histories, current drug use, and related risk behaviors. The study used urinalysis to confirm current drug use, and conducted HIV and HCV testing. Participants were predominantly male (95%), mean age of 40, and all reported injecting heroin. Respondents' reports of initiating MA use were rare up through early 2000s but increased exponentially through the mid-2010s. MA use was predominantly "smoking," heating the drug and inhaling the vapor using a pipe; injecting MA was rare. Current (past 30 day) MA use appears to have plateaued in 2016-2018 with 53-58% of participants reporting no use in the last 30 days, 37-41% reporting low to moderate use (1 to 19 days in last 30 days), and 5-7% reporting very frequent use (20 or more days in last 30 days). This plateau reflects a rough balance between new users and individuals ceasing use. MA use has become a substantial public health problem among PWID in Hai Phong. Initiation into MA use rose exponentially from 2005 to about 2015. Use of MA will likely continue for a substantial number of PWID. Currently, no medication is approved for treating MA disorders in Vietnam. Current psychosocial treatment requires highly trained counselors and months of treatment, so that psychosocial treatment for all PWID with MA disorders is likely beyond the resources available in a middle-income country such as Vietnam. Harm reduction programs implemented by community-based organization staff may provide a way to rapidly address aspects of the current MA epidemic. Such programs could emphasize social support for reducing use where possible and for avoiding escalation of use among persons continuing to use.

Identifiants

pubmed: 34116818
pii: S0740-5472(21)00046-5
doi: 10.1016/j.jsat.2021.108320
pmc: PMC8197775
mid: NIHMS1669758
pii:
doi:

Substances chimiques

Methamphetamine 44RAL3456C
Heroin 70D95007SX

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108320

Subventions

Organisme : NIDA NIH HHS
ID : P30 DA011041
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA041978
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

J Addict Dis. 2008;27(3):13-21
pubmed: 18956525
Soc Sci Med. 2009 Jan;68(1):69-79
pubmed: 18986746
Addict Behav. 2009 Apr;34(4):343-51
pubmed: 19138821
Focus. 2004 Jan;19(1):4-6
pubmed: 15074271
AIDS. 2020 Nov 1;34(13):1875-1882
pubmed: 32910061
Am J Drug Alcohol Abuse. 1976;3(4):557-70
pubmed: 1032764
Drug Alcohol Rev. 2010 Jul;29(4):358-63
pubmed: 20636650
MMWR Morb Mortal Wkly Rep. 2019 Apr 19;68(15):344-349
pubmed: 30998671
AIDS. 2000 Jan 7;14(1):75-83
pubmed: 10714570
Am J Addict. 2004 Mar-Apr;13(2):181-90
pubmed: 15204668
J Infect Dis. 2003 Dec 15;188(12):1820-6
pubmed: 14673760
BMJ. 2006 Feb 18;332(7538):382
pubmed: 16484253
Lancet Psychiatry. 2019 Dec;6(12):985
pubmed: 31777349
Subst Use Misuse. 2017 Jul 3;52(8):1051-1058
pubmed: 28323507
Int J Drug Policy. 2016 Jun;32:50-6
pubmed: 27006257
Curr HIV/AIDS Rep. 2005 Nov;2(4):194-9
pubmed: 16343378
J Psychoactive Drugs. 2018 Nov-Dec;50(5):382-389
pubmed: 30183558
Drug Alcohol Depend. 2011 May 1;115(1-2):145-9
pubmed: 21130584
Sci Rep. 2015 Aug 24;5:13179
pubmed: 26299251
Harm Reduct J. 2015 Oct 16;12:38
pubmed: 26470693
J Subst Abuse Treat. 2007 Jan;32(1):41-52
pubmed: 17175397
Drug Alcohol Rev. 2004 Sep;23(3):287-94
pubmed: 15370008
Aust N Z J Public Health. 2015 Apr;39(2):194-5
pubmed: 25559677
Support Care Cancer. 2019 Dec;27(12):4469-4477
pubmed: 30904948
J Int Neuropsychol Soc. 2004 Jan;10(1):1-14
pubmed: 14751002
Drug Alcohol Depend. 2008 Aug 1;96(3):193-201
pubmed: 18329825
J Food Drug Anal. 2013 Dec;21(4):S42-S45
pubmed: 25278736
AIDS. 1994 Nov;8(11):1630-2
pubmed: 7848607
J Nerv Ment Dis. 1987 Sep;175(9):566-74
pubmed: 3655783
Drug Alcohol Depend. 2017 Oct 1;179:198-204
pubmed: 28800503

Auteurs

Don C Des Jarlais (DC)

New York University School of Global Public Health, New York, NY, USA. Electronic address: Don.desjarlais@nyu.edu.

Jonathan Feelemyer (J)

New York University School of Global Public Health, New York, NY, USA.

Kamyar Arasteh (K)

New York University School of Global Public Health, New York, NY, USA.

Duong Thi Huong (DT)

Haiphong University of Medicine and Pharmacy, Haiphong, Viet Nam.

Khuat Thi Hai Oanh (KTH)

Supporting Community Development Initiatives, Hanoi, Viet Nam.

Pham Minh Khue (PM)

Haiphong University of Medicine and Pharmacy, Haiphong, Viet Nam.

Hoang Thi Giang (HT)

Haiphong University of Medicine and Pharmacy, Haiphong, Viet Nam.

Nham Thi Tuyet Thanh (NTT)

Supporting Community Development Initiatives, Hanoi, Viet Nam.

Jean Pierre Moles (JP)

Pathogenesis and Control of Chronic Infections, Inserm, Etablissement Français du Sang, University of Montpellier, Montpellier, France.

Vu Hai Vinh (VH)

Dept of Infectious and Tropical Diseases, Viet Tiep Hospital, Haiphong, Viet Nam.

Roselyne Vallo (R)

Pathogenesis and Control of Chronic Infections, Inserm, Etablissement Français du Sang, University of Montpellier, Montpellier, France.

Catherine Quillet (C)

Pathogenesis and Control of Chronic Infections, Inserm, Etablissement Français du Sang, University of Montpellier, Montpellier, France.

Delphine Rapoud (D)

Pathogenesis and Control of Chronic Infections, Inserm, Etablissement Français du Sang, University of Montpellier, Montpellier, France.

Laurent Michel (L)

Pierre Nicole Center, French Red Cross, CESP/Inserrm 1018, Paris, France.

Didier Laureillard (D)

Pathogenesis and Control of Chronic Infections, Inserm, Etablissement Français du Sang, University of Montpellier, Montpellier, France; Infectious Diseases Department, Caremeau University Hospital, Nîmes, France.

Nicolas Nagot (N)

Pathogenesis and Control of Chronic Infections, Inserm, Etablissement Français du Sang, University of Montpellier, Montpellier, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH